Cancer chemotherapy

1. Cancer
Chemotherapy
www.freelivedoctor.com

2. www.freelivedoctor.com

3. Cell Cycle
Cell Cycle Specific Agents
• Antimetabolites
• Bleomycin
• Podophyllin Alkaloids
• Plant Alkaloids
Cell Cycle Non-Specific
Agents
• Alkylating Agents
• Antibiotics
•Cisplatin
• Nitrosoureas
www.freelivedoctor.com

4. Resistance to Cytotoxic Drugs
Increased expression of MDR-1 gene for a cell
surface glycoprotein, P-glycoprotein
MDR-1 gene is involved with drug efflux
Drugs that reverse multidrug resistance include
verapamil, quinidine, and cyclosporine
MDR increases resistance to natural drug products
including the anthracyclines, vinca alkaloids, and
epipodophyllotoxins
www.freelivedoctor.com

5. Schematic of P-glycoprotein
www.freelivedoctor.com

6. Alkylating Agents
Nitrogen Mustards Ethylenimines NitrosoureasAlkyl Sulfonates
Cyclophosphamide Thiotepa Busulfan Carmustine
Legend
Drug Class
Sub-class
Prototype Drug
www.freelivedoctor.com

7. Alkylating Agents
Mechanism of Action
Alkylate within DNA at the N7 position of
guanine
Resulting in miscoding through abnormal
base-pairing with thymine or in
depurination by excision of guanine
residues, leading to strand breakage
Cross-linking of DNA and ring cleavage
may also occur
www.freelivedoctor.com

8. Alkylating Agents
Mechanism of Action
www.freelivedoctor.com

9. Nitrogen Mustards
Cyclophosphamide
Ifosfamide
Mechlorethamine
Melphalan
Chlorambucil
www.freelivedoctor.com

10. Cyclophosphamide Metabolism
www.freelivedoctor.com

11. Nitrosoureas
Carmustine
Lomustine
Semustine
Streptozocin-naturally occuring sugar
containing
M.O.A.- cross-link through alkylation of DNA
All cross the blood brain barrier
www.freelivedoctor.com

12. Alkylating-Related Agents
Procarbazine
Dacarbazine
Altretamine
Cisplatin
Carboplatin
www.freelivedoctor.com

13. Platinum Coordination
Complexes
These compounds alkylate N7 of guanine. They cause nephro- and ototoxicity.
To counteract the effects of nephrotoxicity, give mannitol as an osmotic diuretic,
or induce chloride diuresis with 0.1% NaCl.
www.freelivedoctor.com

14. Alkylating Agents
Toxicity
Bone marrow depression, with leukopenia and
thrombocytopenia
Cyclophosphamide/Ifosfamide - hemorrhagic
cystitis
Reduced by coadministration with MESNA
Cisplatin/Carboplatin - ototoxic and nephrotoxic
Nephrotoxicity reduced by chloride diuresis and hydration
www.freelivedoctor.com

15. Alkylating Agents
Therapeutic Uses
Used to treat a wide variety of hematologic and
solid tumors
Thiotepa – ovarian cancer
Busulfan – chronic myeloid leukemia
Nitrosoureas - brain tumors
Streptozocin – insulin-secreting islet cell
carcinoma of the pancreas
www.freelivedoctor.com

16. Antimetabolites
Folic Acid Analogs Purine Analogs Pyrimidine Analogs
Methotrexate Mercaptoguanine Fluorouracil
Legend
Drug Class
Sub-class
Prototype Drug
www.freelivedoctor.com

17. Folic Acid Analogs
Methotrexate
Trimetrexate
Pemetrexed
www.freelivedoctor.com

18. Folate
An essential dietary factor, from which
THF cofactors are formed which
provide single carbon groups for the
synthesis of precursors of DNA and
RNA
To function as a cofactor folate must be
reduced by DHFR to THF
www.freelivedoctor.com

19. Methotrexate
Mechanism of Action
The enzyme DHFR is the 1º site of action
MTX prevents the formation of THF, causing
an intracellular deficiency of folate
coenzymes and accumulation of the toxic
inhibitory substrate, DHF polyglutamate
The one carbon transfer reactions for purine
and thymidylate synthesis cease,
interrupting DNA and RNA synthesis
www.freelivedoctor.com

20. Major Enzymatic Reactions Requiring Folates as
Substrates*
GAR
GAR transformylase
AICAR IMP
AMP
GMP
AICAR transformylase
10-formylTHF
Formate
+
THF
(3)
DHF
b
e
5,10-CH
2
THF 5-CH
3
THF
c
Methionine
Homocysteine
d
(2)
dUMP
dTMP
DNA
a
(1)
a,thymidylate synthase; b, dihydrofolate reductase; c, methylenetetrahydrofolate reductase;
d, methionine synthase; e, serine hydroxymethyl transferase
*from Bowen
www.freelivedoctor.com

21. Resistance
www.freelivedoctor.com

22. Methotrexate
Mechanism of Resistance
1.Decreased drug transport
2.Altered DHFR
3.Decreased polyglutamate formation
4.Increased levels of DHFR
www.freelivedoctor.com

23. Methotrexate
Therapeutic Uses
Methotrexate- psoriasis, rheumatoid
arthritis, acute lymphoblastic leukemia,
meningeal leukemia, choriocarcinoma,
osteosarcoma, mycosis fungoides,
Burkitt’s and non-Hodgkin’s
lymphomas, cancers of the breast,
head and neck, ovary, and bladder
www.freelivedoctor.com

24. Trimetrexate
Therapeutic Uses
Trimetrexate- Pneumocystis carinii
pneumonia, metastatic colorectal
carcinoma, head and neck carcinoma,
pancreatic carcinoma, non-small cell
carcinoma of the lung
www.freelivedoctor.com

25. Pemetrexed
Therapeutic Uses
Pemetrexed- Mesothelioma
www.freelivedoctor.com

26. Methotrexate
Toxicity
Bone marrow suppression
Rescue with leucovorin (folinic acid)
Nephrotoxic
give sodium bicarbonate to alkalinize the
urine
www.freelivedoctor.com

27. Purine Antagonists
Mercaptopurine
Thioguanine
Fludarabine Phosphate
Cladribine
www.freelivedoctor.com

28. Mercaptopurine/Thioguanine
Must metabolized by HGPRT to the
nucleotide form
This form inhibits numerous enzymes of
purine nucleotide interconversion
www.freelivedoctor.com

29. Fludarabine Phosphate
M.O.A.- phosphorylated intracellularly by
deoxycytidine kinase to the triphosphate
form
The metabolite inhibits DNA polymerase-α
and ribonucleotide reductase
Induces apoptosis
Tx- non-Hodgkin’s lymphoma and chronic
lymphocytic leukemia
www.freelivedoctor.com

30. Cladribine
M.O.A. -phosphorylated by deoxycytidine
kinase and is incorporated into DNA
Causes DNA strand breaks
Tx- hairy cell leukemia, chronic
lymphocytic leukemia, and non-Hodgkin’s
lymphoma
www.freelivedoctor.com

31. Pyrimidine Antagonists
Fluorouracil - S-phase
Cytarabine
Gemcitabine
Capecitabine
www.freelivedoctor.com

32. Figure 2. This figure illustrates the effects of MTX and 5-FU on the
biochemical pathway for reduced folates.
X
X
5-FU
MTX
www.freelivedoctor.com

33. Mechanism of Action 5-FU
5-FU inhibits thymidylate synthase
therefore causing depletion of
Thymidylate
5-FU is incorporated into DNA
5-FU inhibits RNA processing
www.freelivedoctor.com

34. Activation of 5-FU
www.freelivedoctor.com

35. Therapeutic Uses of 5-FU
Metastatic carcinomas of the breast and
the GI tract
hepatoma
carcinomas of the ovary, cervix, urinary
bladder, prostate, pancreas, and
oropharyngeal areas
Combined with levamisole for Tx of colon
cancer
www.freelivedoctor.com

36. Cytarabine
It is activated to 5’ monophosphate
(AraCMP) by deoxycytidine kinase
Through a series of reactions it forms
the diphosphate (AraCDP) and
triphosphate (AraCTP) nucleotides
Accumulation of AraCTP potently
inhibits DNA synthesis
Inhibition of DNA synthesis is due to
competitive (-) of polymerases and
interference of chain elongation
www.freelivedoctor.com

37. Cytarabine
It is a potent inducer of tumor cell
differentiation
Fragmentation of DNA and evidence of
apoptosis is noticed in treated cells
AraC is cell-cycle specific agent, it kills
cells in the S-phase
www.freelivedoctor.com

38. Cytarabine
Mechanisms of Resistance
deficiency of deoxycytidine kinase
increased CTP synthase activity
increased cytidine deaminase activity
decreased affinity of DNA polymerase for
AraCTP
decrease ability of the cell to transport
AraC
www.freelivedoctor.com

39. Cytarabine
Therapeutic Uses
Induction of remissions in acute leukemia
Treats meningeal leukemia
Treatment of acute nonlymphocytic
leukemia
In combination with anthracyclines or
mitoxantrone it can treat non-Hodgkin’s
lymphomas
www.freelivedoctor.com

40. Cytarabine
Toxicities
Nausea
acute myelosuppression
stomatitis
alopecia
www.freelivedoctor.com

41. Gemcitabine
Gemcitabine is S-phase specific
it is a deoxycytidine antimetabolite
it undergoes intracellular conversion to
gemcitabine monophosphate via the
enzyme deoxycytidine kinase
it is subsequently phosphorylated to
gemcitabine diphosphate and gemcitabine
triphosphate
www.freelivedoctor.com

42. Gemcitabine
Gemcitabine triphosphate competes with
deoxycytidine triphosphate (dCTP) for
incorporation into DNA strands
do to an addition of a base pair before
DNA polymerase is stopped, Gemcitabine
inhibits both DNA replication and repair
Gemcitabine-induced cell death has
characteristics of apoptosis
www.freelivedoctor.com

43. Gemcitabine
Therapeutic Uses
Gemcitabine treats a variety of solid
tumors
very effective in the treatment of
pancreatic cancer
 small cell lung cancer
carcinoma of the bladder, breast, kidney,
ovary, and head and neck
www.freelivedoctor.com

44. Cancer
Chemotherapy
Jillian H. Davis
Department of Pharmacology
Howard University
www.freelivedoctor.com

45. Plant Alkaloids
Vinca Alkaloids Podophyllotoxins Camptothecins Taxanes
Vinblastine Etoposide Topotecan Paclitaxel
www.freelivedoctor.com

46. Vinca Alkaloids
Vinblastine
Vincristine
Vinorelbine
www.freelivedoctor.com

47. Vinca Alkaloids
3
3
Inhibit microtubules
(spindle), causing
metaphase cell arrest
in M phase.
www.freelivedoctor.com

48. Vinca Alkaloids
Mechanism of Action
Binds to the microtubular protein tubulin in a
dimeric form
The drug-tubulin complex adds to the forming
end of the microtubules to terminate assembly
Depolymerization of the microtubules occurs
Resulting in mitotic arrest at metaphase,
dissolution of the mitotic spindle, and
interference with chromosome segregation
CCS agents- M phase
www.freelivedoctor.com

49. Vinblastine
Toxicity
Nausea
Vomiting
Marrow depression
Alopecia
www.freelivedoctor.com

50. Vinblastine
Therapeutic Uses
Systemic Hodgkin’s disease
Lymphomas
www.freelivedoctor.com

51. Vincristine
Toxicity
Muscle weakness
Peripheral neuritis
www.freelivedoctor.com

52. Vincristine
Therapeutic Uses
With prednisone for remission of Acute
Leukemia
www.freelivedoctor.com

53. Vinorelbine
Toxicity
Granulocytopenia
Therapeutic Uses
 non-small cell lung cancer
www.freelivedoctor.com

54. Podophyllotoxins
Etoposide (VP-16)
Teniposide (VM-26)
Semi-synthetic derivatives of podophyllotoxin extracted
from the root of the mayapple
www.freelivedoctor.com

55. Podophyllotoxins
Mechanism of Action
Blocks cells in the late S-G
2
phase of the
cell cycle through inhibition of
topoisomerase II
Resulting in DNA damage through strand
breakage induced by the formation of a
ternary complex of drug, DNA, and
enzyme
www.freelivedoctor.com

56. Podophyllotoxins
Toxicity
Nausea
Vomiting
Alopecia
Hematopoietic and lymphoid toxicity
www.freelivedoctor.com

57. Podophyllotoxins
Therapeutic Uses
Monocytic Leukemia
Testicular cancer
Oat cell carcinoma of the lung
www.freelivedoctor.com

58. Camptothecins
Topotecan
Irinotecan
www.freelivedoctor.com

59. Camptothecins
Mechanism of Action
Interfere with the activity of Topoisomerase I
Resulting in DNA damage
Irinotecan- a prodrug that is metabolized to
an active Top I inhibitor, SN-38
www.freelivedoctor.com

60. Camptothecins
Toxicity
Topotecan
Neutropenia, thrombocytopenia, anemia
Irinotecan
Severe diarrhea, myelosuppression
www.freelivedoctor.com

61. Camptothecins
Therapeutic Uses
Topotecan- metastatic ovarian cancer
(cisplatin-resistant)
Irinotecan- colon and rectal cancer
www.freelivedoctor.com

62. Taxanes
Paclitaxel (Taxol)
Docetaxel
Alkaloid esters derived from the Western
and European Yew
www.freelivedoctor.com

63. Taxanes
Mechanism of Action
Mitotic “spindle poison” through the
enhancement of tubulin polymerization
www.freelivedoctor.com

64. Taxanes
Toxicity
Paclitaxel
Neutropenia, thrombocytopenia
Peripheral neuropathy
Docetaxel
Bone marrow suppression
Neurotoxicity
Fluid retention
www.freelivedoctor.com

65. Taxanes
Therapeutic Uses
Paclitaxel- ovarian and advanced breast
cancer
Docetaxel- advanced breast cancer
www.freelivedoctor.com

66. Antibiotics
Anthracyclines- Doxorubicin &
Daunorubicin
Dactinomycin
Plicamycin
Mitomycin
Bleomycin
www.freelivedoctor.com

67. Anthracyclines
Doxorubicin
Daunorubicin
www.freelivedoctor.com

68. Anthracyclines
Mechanism of Action
High-affinity binding to DNA through
intercalation, resulting in blockade of DNA
and RNA synthesis
DNA strand scission via effects on Top II
Binding to membranes altering fluidity
Generation of the semiquinone free radical
and oxygen radicals
www.freelivedoctor.com

69. Anthracyclines
Toxicity
Bone marrow depression
Total alopecia
Cardiac toxicity
www.freelivedoctor.com

70. Anthracyclines
Therapeutic Uses
Doxorubicin- carcinomas of the breast,
endometrium, ovary, testicle, thyroid, and
lung, Ewing’s sarcoma, and osteosarcoma
Daunorubicin- acute leukemia
www.freelivedoctor.com

71. Dactinomycin
Mechanism of Action
Binds to double stranded DNA through
intercalation between adjacent guanine-
cytosine base pairs
Inhibits all forms of DNA-dependent RNA
synthesis
www.freelivedoctor.com

72. Dactinomycin
Toxicity
Bone marrow depression
Oral ulcers
Skin eruptions
Immunosuppression
www.freelivedoctor.com

73. Dactinomycin
Therapeutic Uses
Wilms’ tumors
Gestational choriocarinoma with MTX
www.freelivedoctor.com

74. Plicamycin
Mechanism of Action
Binds to DNA through an antibiotic-Mg
2+
complex
This interaction interrupts DNA-directed
RNA synthesis
www.freelivedoctor.com

75. Plicamycin
Toxicity
Hypocalcemia
Bleeding disorders
Liver toxicity
www.freelivedoctor.com

76. Plicamycin
Therapeutic Uses
Testicular cancer
Hypercalcemia
www.freelivedoctor.com

77. Mitomycin
Mechanism of Action
Bioreductive alkylating agent that
undergoes metabolic reductive activation
through an enzyme-mediated reduction to
generate an alkylating agent that cross-
links DNA
www.freelivedoctor.com

78. Mitomycin
Toxicity
Severe myelosuppression
Renal toxicity
Interstitial pneumonitis
www.freelivedoctor.com

79. Mitomycin
Therapeutic Uses
Squamous cell carcinoma of the cervix
Adenocarcinomas of the stomach,
pancreas, and lung
2
nd
line in metastatic colon cancer
www.freelivedoctor.com

80. Bleomycin
Acts through binding to DNA, which
results in single and double strand breaks
following free radical formation and
inhibition of DNA synthesis
The DNA fragmentation is due to oxidation
of a DNA-bleomycin-Fe(II) complex and
leads to chromosomal aberrations
CCS drug that causes accumulation of
cells in G
2
www.freelivedoctor.com

81. Bleomycin
Toxicity
Lethal anaphylactoid reactions
Blistering
Pulmonary fibrosis
www.freelivedoctor.com

82. Bleomycin
Therapeutic Uses
Testicular cancer
Squamous cell carcinomas of the head
and neck, cervix, skin, penis, and rectum
Lymphomas
Intracavitary therapy in ovarian and breast
cancers
www.freelivedoctor.com

83. Hormonal Agents
Estrogen & Androgen
Inhibitors
Gonadotropin-Releasing
Hormone Agonists
Aromatase Inhibitors
Tamoxifen Leuprolide Aminogluthethimide
Legend
Drug Class
Sub-class
Prototype Drug
www.freelivedoctor.com

84. Anti-Estrogens
Tamoxifen (SERMs)
Raloxifene (SERMs)
Faslodex
www.freelivedoctor.com

85. Tamoxifen
Selective estrogen receptor modulator (SERM), have both
estrogenic and antiestrogenic effects on various tissues
Binds to estrogen receptors (ER) and induces conformational
changes in the receptor
Has antiestrogenic effects on breast tissue.
The ability to produce both estrogenic and antiestrogenic
affects is most likely due to the interaction with other
coactivators or corepressors in the tissue and the binding with
different estrogen receptors, ERa and ERb
Subsequent to tamoxifen ER binding, the expression of
estrogen dependent genes is blocked or altered
Resulting in decreased estrogen response.
Most of tamoxifen’s affects occur in the G1 phase of the cell
cycle
www.freelivedoctor.com

86. Tamoxifen
Toxicity
Hot flashes
Fluid retention
nausea
www.freelivedoctor.com

87. Tamoxifen
Therapeutic Uses
Tamoxifen can be used as primary therapy for
metastatic breast cancer in both men and
postmenopausal women
Patients with estrogen-receptor (ER) positive
tumors are more likely to respond to tamoxifen
therapy, while the use of tamoxifen in women
with ER negative tumors is still investigational
When used prophylatically, tamoxifen has been
shown to decrease the incidence of breast
cancer in women who are at high risk for
developing the disease
www.freelivedoctor.com

88. Anti-Androgen
Flutamide
Antagonizes androgenic effects
approved for the treatment of prostate cancer
www.freelivedoctor.com

89. Gonadotropoin-Releasing Hormone
Agonists
Leuprolide
Goserelin
www.freelivedoctor.com

90. Gonadotropoin-Releasing Hormone
Agonist
Mechanism of Action
Agents act as GnRH agonist, with
paradoxic effects on the pituitary
Initially stimulating the release of FSH and
LH, followed by inhibition of the release of
these hormones
Resulting in reduced testicular androgen
synthesis
www.freelivedoctor.com

91. Gonadotropoin-Releasing Hormone
Agonist
Toxicity
Gynecomastia
Edema
thromboembolism
www.freelivedoctor.com

92. Gonadotropoin-Releasing Hormone
Agonist
Therapeutic Uses
Metastatic carcinoma of the prostate
Hormone receptor-positive breast cancer
www.freelivedoctor.com

93. Aromatase Inhibitors
Aminogluthethimide
Anastrozole
www.freelivedoctor.com

94. Aminogluthethimide
Mechanism of Action
Inhibitor of adrenal steroid synthesis at the
first step, conversion of cholesterol of
pregnenolone
Inhibits the extra-adrenal synthesis of
estrone and estradiol
Inhibits the enzyme aromatase that
converts androstenedione to estrone
www.freelivedoctor.com

95. www.freelivedoctor.com

96. Aminogluthethimide
Toxicity
Dizziness
Lethargy
Visual blurring
Rash
Therapeutic Uses
ER- and PR-positive metastatic breast
cancer
www.freelivedoctor.com

97. Anastrozole
A new selective nonsteroidal inhibitor of
aromatase
Treats advanced estrogen and
progesterone receptor positive breast
cancer that is no longer responsive to
tamoxifen
www.freelivedoctor.com

98. Miscellaneous AntiCancer Agents
Asparaginase
Hydroxurea
Mitoxantrone
Mitotane
Retinoic Acid Derivatives
Amifostine
www.freelivedoctor.com

99. Asparaginase
An enzyme isolated from bacteria
Causes catabolic depletion of serum
asparagine to aspartic acid and ammonia
Resulting in reduced blood glutamine levels
and inhibition of protein synthesis
Neoplastic cells require external source of
asparagine
Treats childhood acute leukemia
Can cause anaphylactic shock
www.freelivedoctor.com

100. Hydroxyurea
An analog of urea
Inhibits the enzyme ribonucleotide reductase
Resulting in the depletion of
deoxynucleoside triphosphate pools
Thereby inhibiting DNA synthesis
S-phase specific agent
Treats melanoma and chronic myelogenous
leukemia
www.freelivedoctor.com

101. Mitoxantrone
Structure resembles the anthracyclines
Binds to DNA to produce strand breakage
Inhibits DNA and RNA synthesis
Treats pediatric and adult acute
myelogenous leukemia, non-Hodgkin’s
lymphomas, and breast cancer
Causes cardiac toxicity
www.freelivedoctor.com

102. Mechanisms & Actions of Useful
Chemotherapeutic Drugs in Neoplastic
Disease
www.freelivedoctor.com